Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS)

American Journal of Cardiology

Volumn 88, Issue 3, 2001, Pages 214-218

  Chandra, Harish R ^a   Choudhary, Nivedita ^a   O'Neill, Carol ^a   Boura, Judith ^a   Timmis, Gerald C ^a   O'Neill, William W ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN G; TROPONIN T;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CAUCASIAN; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REINFECTION; SEROPREVALENCE; SMOKING;

ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; ANGINA, UNSTABLE; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SYNDROME;

EID: 0035422315     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01628-9     Document Type: Article

References (28)

1. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
2. Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease
3. Infections, inflammation, and the risk of coronary heart disease
4. Chronic infections and coronary heart disease: Is there a link?
5. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem
6. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study
7. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
8. Atherosclerosis - An inflammatory disease
9. Infections caused by Chlamydia pneumoniae strain TWAR
10. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity
11. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis
12. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease
13. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies
14. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
15. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
16. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Fragmin during Instability in Coronary Artery Disease
17. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
18. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
19. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
20. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
21. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland
22. Chlamydia infections and heart disease linked through antigenic mimicry
23. Autoimmunity and atherosclerosis
24. Molecular mediators of arterial inflammation: A role for microbial products?
25. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
26. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis
27. Rationale, and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction. The WIZARD (Weekly Intervention with Zithromax [Azithromycin] for Atherosclerosis and Its Related Disorders) Trial
28. Description, and status of the Azithromycin, and Coronary Events Study (ACES)